Company: IMNN
Filing Date: 2025-05-12
Form Type: 10-Q
Source: 0001641172-25-009572
Chunk: 77

Company: Imunon, Inc.
Filing Date: 2025-05-12
Form: 10-Q
Item: Part II, Item 1
Chunk 77
---
We
are not currently a party to any material legal proceedings.

Item
1A. Risk Factors

There
have been no material changes to our risk factors from those disclosed under “Risk Factors” in Part I, Item 1A of our 2024
Annual Report on Form 10-K. The risks and uncertainties described in our 2024 Annual Report on Form 10-K are not the only ones we face.
Additional risks and uncertainties not presently known to us or that we currently deem immaterial may also materially adversely affect
our business, financial condition, or results of operations.

Item
2. Unregistered Sales of Equity Securities and Use of Proceeds.

None.

Item
3. Defaults Upon Senior Securities.

None.

Item
4. Mine Safety Disclosures.

Not
applicable.

Item
5. Other Information.

During
the quarter ended March 31, 2025, no directors or executive officers entered into, modified or terminated, contracts, instructions or
written plans for the sale or purchase of the Company’s securities that were intended to satisfy the affirmative defense conditions
of Rule 10b5-1.

27

Item
6. Exhibits. 

    10.1++
     
    Offer Letter of Employment, dated February 1, 2025, between Imunon, Inc. and Douglas Faller, incorporated by reference to Exhibit 10.1 to the Current Report on Form 8-K of the Company filed on February 10, 2025 (SEC File No. 001-15911).

    31.1+
     
    Certification of Chief Executive Officer pursuant to Rule 13a-14(a)/15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

    31.2+
     
    Certification of Chief Financial Officer pursuant to Rule 13a-14(a)/15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

    32.1*
     
    Certification pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

    101**
     
    The
    following materials from the Company’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2025 formatted in XBRL
    (Extensible Business Reporting Language): (i